Operating Lease, Right-of-Use Asset of IOVANCE BIOTHERAPEUTICS, INC. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
IOVANCE BIOTHERAPEUTICS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • IOVANCE BIOTHERAPEUTICS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $48,763,000, a 27% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

IOVANCE BIOTHERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $48,763,000 -$17,980,000 -27% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $49,949,000 -$19,174,000 -28% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $50,903,000 -$20,613,000 -29% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $55,201,000 -$7,314,000 -12% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $66,743,000 +$478,000 +0.72% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $69,123,000 +$1,492,000 +2.2% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $71,516,000 +$1,085,000 +1.5% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $62,515,000 -$10,500,000 -14% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $66,265,000 -$2,003,000 -2.9% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $67,631,000 -$3,214,000 -4.5% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $70,431,000 -$3,044,000 -4.1% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $73,015,000 +$4,032,000 +5.8% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $68,268,000 -$4,155,000 -5.7% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $70,845,000 +$18,337,000 +35% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $73,475,000 +$18,344,000 +33% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $68,983,000 +$14,227,000 +26% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $72,423,000 +$61,741,000 +578% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $52,508,000 +$45,028,000 +602% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $55,131,000 +$45,826,000 +492% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $54,756,000 +$44,061,000 +412% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $10,682,000 -$3,056,000 -22% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $7,480,000 -$4,239,000 -36% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $9,305,000 -$652,000 -6.5% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 $10,695,000 +$10,695,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $13,738,000 30 Sep 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 $11,719,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $9,957,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-Q 07 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.